ES
Estrella Immunopharma, Inc. Warrant (ESLAW)
NASDAQ·Healthcare·Biotechnology
$0.07
-12.39%
Mkt Cap $3.19M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$236.90
Range $160.68 – $278.10
Implied Upside
+338328.6%
Consensus $236.90 vs current $0.07